These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19602278)

  • 1. Tetraspanins regulate cell-to-cell transmission of HIV-1.
    Krementsov DN; Weng J; Lambelé M; Roy NH; Thali M
    Retrovirology; 2009 Jul; 6():64. PubMed ID: 19602278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1 infection.
    Tippett E; Cameron PU; Marsh M; Crowe SM
    J Leukoc Biol; 2013 Jun; 93(6):913-20. PubMed ID: 23570947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.
    Ceccherini-Silberstein F; Malet I; Fabeni L; Dimonte S; Svicher V; D'Arrigo R; Artese A; Costa G; Bono S; Alcaro S; Monforte Ad; Katlama C; Calvez V; Antinori A; Marcelin AG; Perno CF
    J Antimicrob Chemother; 2010 Nov; 65(11):2305-18. PubMed ID: 20817922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line.
    Grigorov B; Attuil-Audenis V; Perugi F; Nedelec M; Watson S; Pique C; Darlix JL; Conjeaud H; Muriaux D
    Retrovirology; 2009 Mar; 6():28. PubMed ID: 19284574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of dolutegravir failure with R263K mutation.
    Cardoso M; Baptista T; Diogo I; Aleixo MJ; Marques N; Mansinho K; Gomes P
    AIDS; 2018 Nov; 32(17):2639-2640. PubMed ID: 30379690
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity.
    Fun A; Van Baelen K; van Lelyveld SF; Schipper PJ; Stuyver LJ; Wensing AM; Nijhuis M
    J Antimicrob Chemother; 2010 Nov; 65(11):2300-4. PubMed ID: 20736234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance.
    Liang J; Mesplède T; Oliveira M; Anstett K; Wainberg MA
    J Virol; 2015 Nov; 89(22):11269-74. PubMed ID: 26311878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance.
    Hachiya A; Ode H; Matsuda M; Kito Y; Shigemi U; Matsuoka K; Imamura J; Yokomaku Y; Iwatani Y; Sugiura W
    Antiviral Res; 2015 Jul; 119():84-8. PubMed ID: 25956162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence showing that tetraspanins inhibit HIV-1-induced cell-cell fusion at a post-hemifusion stage.
    Symeonides M; Lambelé M; Roy NH; Thali M
    Viruses; 2014 Mar; 6(3):1078-90. PubMed ID: 24608085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens.
    da Silva D; Van Wesenbeeck L; Breilh D; Reigadas S; Anies G; Van Baelen K; Morlat P; Neau D; Dupon M; Wittkop L; Fleury H; Masquelier B
    J Antimicrob Chemother; 2010 Jun; 65(6):1262-9. PubMed ID: 20388636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanins, Another Piece in the HIV-1 Replication Puzzle.
    Suárez H; Rocha-Perugini V; Álvarez S; Yáñez-Mó M
    Front Immunol; 2018; 9():1811. PubMed ID: 30127789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles.
    Fan Y; Pionneau C; Cocozza F; Boëlle PY; Chardonnet S; Charrin S; Théry C; Zimmermann P; Rubinstein E
    J Extracell Vesicles; 2023 Aug; 12(8):e12352. PubMed ID: 37525398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation.
    Jaffré J; Armenia D; Bellocchi MC; Wirden M; Carioti L; Lambert S; Valantin MA; Nguyen T; Simon A; Katlama C; Andreoni M; Perno CF; Calvez V; Ceccherini-Silberstein F; Marcelin AG; Todesco E
    J Antimicrob Chemother; 2017 May; 72(5):1537-1539. PubMed ID: 28088769
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.
    Garrido C; Geretti AM; Zahonero N; Booth C; Strang A; Soriano V; De Mendoza C
    J Antimicrob Chemother; 2010 Feb; 65(2):320-6. PubMed ID: 20007331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraspanins are involved in Schwann cell-axon interaction.
    Chernousov MA; Stahl RC; Carey DJ
    J Neurosci Res; 2013 Nov; 91(11):1419-28. PubMed ID: 24038174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.
    Tschochner M; Chopra A; Maiden TM; Ahmad IF; James I; Furrer H; Günthard HF; Mallal S; Rauch A; John M
    Antivir Ther; 2009; 14(7):953-64. PubMed ID: 19918099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.
    Gutiérrez C; Hernández-Novoa B; Pérez-Elías MJ; Moreno AM; Holguín A; Dronda F; Casado JL; Moreno S
    HIV Clin Trials; 2013; 14(1):10-6. PubMed ID: 23372110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin is a component of the HIV-1 virological presynapse and contributes to the inhibition of cell-cell fusion.
    Roy NH; Lambelé M; Chan J; Symeonides M; Thali M
    J Virol; 2014 Jul; 88(13):7645-58. PubMed ID: 24760896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
    Malet I; Subra F; Charpentier C; Collin G; Descamps D; Calvez V; Marcelin AG; Delelis O
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance.
    Fun A; Leitner T; Vandekerckhove L; Däumer M; Thielen A; Buchholz B; Hoepelman AIM; Gisolf EH; Schipper PJ; Wensing AMJ; Nijhuis M
    Retrovirology; 2018 Jan; 15(1):1. PubMed ID: 29304821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.